Alpha-1 Antitrypsin Panel
Alpha-1 Antitrypsin Deficiency (AATD) is a genetic condition that may result in serious lung disease in adults and/or liver disease at any age. Clinical practice guidelines from the American Thoracic Society, European Respiratory Society, the American Association for Respiratory Care and the Alpha-1 Foundation recommend that all individuals with chronic obstructive pulmonary disease (COPD) and all individuals with unexplained chronic liver disease should be tested for AATD.
As part of the nation’s leading respiratory hospital, National Jewish Health Advanced Diagnostic Laboratories has extensive experience developing tests that help physicians accurately diagnose complex diseases like AATD.
About Alpha-1 Antitrypsin Test Panel
Our new Alpha-1 screening panel (test code: A1LGP)
automatically tests both AATD levels and genetic variants, including 20 single nucleotide polymorphisms (SNPs) in the human SERPINA1 gene. Pi-typing or whole exome sequencing also is performed when appropriate.
- Most complete screening test available in the U.S.
- Detects both prevalent and rare genetic variants, including the M/M allele
- AATD levels and genotyping in a single report
How to Order
Questions? Call 800.550.6227 or email firstname.lastname@example.org to speak with a client services representative.